Glaxo bags €2.5bn, all negative, Dea €4bn
Most investment grade corporate bonds issued over the past weeks have had intermediate to longer tenors, but on Monday issuance tilted towards the shorter end, as GlaxoSmithKline printed two negative yielding tranches.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: